PepGen financials
$2.34−9.65%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross margin | — | — | — | — |
| Operating income | -$93.6M | -$97.7M | -$84.8M | -$68.3M |
| Net income | -$89.7M | -$90.0M | -$78.6M | -$69.1M |
| Net margin | — | — | — | — |
| Diluted EPS | $-2.12 | $-2.85 | $-3.30 | $-4.42 |
| EBITDA | -$92.2M | -$96.2M | -$83.6M | -$67.8M |
| Operating cash flow | -$81.6M | -$82.4M | -$69.0M | -$59.3M |
| Free cash flow | -$81.9M | -$82.9M | -$71.6M | -$63.0M |
| Diluted shares | 42.2M | 31.6M | 23.8M | 15.6M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $60.5M | $49.4M | $80.8M | $181.8M |
| Short-term investments | $87.9M | $70.8M | $29.6M | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $173.9M | $150.9M | $143.1M | $217.4M |
| Total liabilities | $26.5M | $32.3M | $34.6M | $37.8M |
| Shareholders' equity | $147.4M | $118.6M | $108.4M | $179.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology